Andersen T,Ueland T,Ghukasyan Lakic T,Åkerblom A,Bertilsson M,Aukrust P,Michelsen AE,James SK,Becker RC,Storey RF,Wallentin L,Siegbahn A,Kontny F (2019b). C-X-C Ligand A . .16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes. , 39(11) : 2402-2410.
Cai G,Zhou W,Lu Y,Chen P,Lu Z,Fu Y .2016 .Aspirin resistance and other aspirin-related concerns. Neurol. Sci., 37(2) : 181-9.
Dai XM,Jan BW,Alexander KP .2016 .Acute coronary syndrome in the older adults. J. Geriatr. Cardiol., 13(2) : 101.
Gibson CM,Schomig A .2004 .Coronary and myocardial angiography: Angiographic assessment of both epicardial and myocardial perfusion. Circulation, 109(25) : 3096-3105.
Han Y,Guo J,Zheng Y,Zang H,Su X,Wang Y,Chen S,Jiang T,Yang P,Chen J,Jiang D,Jing Q,Liang Z,Liu H,Zhao X,Li J,Li Y,Xu B,Stone GW .2015 .Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: The BRIGHT randomized clinical trial. JAMA, 313(13) : 1336-1346.
He CB,Li Q,Ye YC,Zhao XL,Tu CC,Zeng Y .2020 .Effects of clopidogrel resistence and CYP2C19 genotype on the clinical prognosis of patients with acute coronary syndrome undergoing percutaneous coronary intervention. Zhonghua Xin Xue Guan Bing Za Zhi., 48(9) : 765-771.
Hu ZB,Chen Y,Gong YX,Gao M,Zhang Y,Wang GH,Tang RN,Liu H,Liu BC,Ma KL .2016 .Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease. Int. J. Med. Sci., 13(11) : 858-867.
Jia H,Lu C,Sun P C .2017 .Intracoronary administration of tirofiban during percutaneous coronary intervention facilitates patients with acute coronary syndrome. Oncotarget., 8(63) : 107303-107311.
Jin G .2017 .The relationship between serum CXCL16 level and carotid vulnerable plaque in patients with ischemic stroke. Eur. Rev. Med, 21(17) : 3911-3915.
Kingma JG,Cardiovasc JG .2019 .Effect of Platelet GPIIb/IIIa Receptor Blockade With MK383 on Infarct Size and Myocardial Blood Flow in a Canine Reocclusion Model. , 24(2) : 182-192.
Li SW,Feng X,Xu H,Chen KJ H .2018 .Comparison on Anticoagulation and Antiplatelet Aggregation Effects of Puerarin with Heparin Sodium and Tirofiban Hydrochloride: An In Vitro Study. Chin. J. Integr. Med, 24(2) : 103-108.
Liang T,Liu M,Wu C,Zhang Q,Lu L,Wang Z L .2017 .Risk factors for no-reflow phenomenon after percutaneous coronary intervention in patients with acute coronary syndrome. Rev. Invest. Clin., 69(3) : 139-145.
Limdi NA,Cavallari LH,Lee CR,Hillegass WB,Holmes AM,Skaar TC,Pisu M,Dillon C,Beitelshees AL,Empey PE,Duarte JD,Diaby V,Gong Y,Johnson JA,Graves J,Garbett S,Zhou Z,Peterson JF .2020 .Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data. , 20(5) : 724-735.
Ma AJ,Zhu XY,Yang SN,Pan XD,Wang T,Wang Y,Xiao X,Liu SH .2018 .Associations of CXCL16, miR-146a and miR-146b in atherosclerotic apolipoprotein E-knockout mice. Mol. Med, 18(3) : 2995-3002.
Nazari A,Sardoo AM,Fard ET,Khorramdelazad H,Hassanshahi G,Nadimi AE .2017 .Plasma CXCL16 level is associated with cardiovascular disease in iranian hemodialysis patients. Biomed, 10(1) : 01-07.
Nemska S,Monassier L,Gassmann M,Frossard N,Tavakoli R .2016 .Kinetic mRNA profiling in a rat model of left-ventricular hypertrophy reveals early expression of chemokines and their receptors. PLoS One, 11(8) : e0161273.
.2016 .Correction to: 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: An update of the 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 134(13) : e298.
Nosseir N,Abdel-messeih P,Bakheet O,Shafy SA .2019 .Evaluation of C-reactive protein and cxcl16 in acute coronary syndrome. Egyptian Journal of Radiation Sciences and Applications, : 157-163.
Sanchis-Gomar F,Perez-Quilis C,Leischik R,Lucia A .2016 .Epidemiology of coronary heart disease and acute coronary syndrome. Ann. Transl. Med, 4(13) : 256.
Shen ZJ,Chen XA,Wang YJ,Guo W,Chen TJ,Wang XL .2017 .Correlation between CYP2C19 Gene Polymorphism with Clopidogrel Resistance and Distribution of Chinese Medicine Syndrome in 229 Acute Coronary Syndrome Patients. Zhongguo Zhong Xi Yi Jie He Za Zhi, 37(3) : 291-296.
Vayne C,Guéry EA,Rollin J,Baglo T,Petermann R,Gruel Y .2020 .Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia. J. Clin. Med, 9 : 2212.
Wei P,Huang YJ,Zuo XH,Zhang YG,Tao ZQ,Qiu CR,Zhang Q,Yang XJ,Fu Q .2016 .Clinical effects of treatment with tirofiban on patients with high-risk NSTE-ACS after PCI. Eur. Rev. Med, 20(7) : 1356-1359.
Mozaffarian D,Benjamin EJ,Go AS,Arnett DK,Blaha MJ,Cushman M,Das SR,de Ferranti S,Després JP,Fullerton HJ,Howard VJ,Huffman MD,Isasi CR,Jiménez MC,Judd SE,Kissela BM,Lichtman JH,Lisabeth LD,Liu S,Mackey RH,Magid DJ,McGuire DK,Mohler ER,Moy CS,Muntner P,Mussolino ME,Nasir K,Neumar RW,Nichol G,Palaniappan L,Pandey DK,Reeves MJ,Rodriguez CJ,Rosamond W,Sorlie PD,Stein J,Towfighi A,Turan TN,Virani SS,Woo D,Yeh RW,Turner MB .2016 .. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association, 133(4) : 447-454.
Xing J,Liu Y,Chen T Y .2018 .Correlations of chemokine CXCL16 and TNF-α with coronary atherosclerotic heart disease. Exp. Ther. Med, 15(1) : 773-776.
Yang M,Huo X,Miao Z,Wang Y .2019 .Platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban in acute ischemic stroke. , 79(5) : 515-529.
Yetgin T,Boersma E,Smits PC,de Vries AG,Huijskens E,Zijlstra F,van Geuns RJM .2018 .One-year efficacy and safety of routine prasugrel in patients with acute coronary syndromes treated with percutaneous coronary intervention: Results of the prospective rijnmond collective cardiology research study. Neth. Heart. J., 26(7-8) : 393-400.
Zhang F,Su S,Hou Y,Zhao L,Wang Z,Liu F,Wu F,Zhang L F .2020 .Effects (MACE and bleeding events) of ticagrelor combined with omeprazole on patients with acute myocardial infarction undergoing primary PCI. , 61(5) : 306-310.